Fig. 2From: Effects of SGLT2 inhibitors on cardiac function and health status in chronic heart failure: a systematic review and meta-analysisForest plot for meta-analysis and subgroup analysis according to EF(A), type of SGLT2i(B) and age(C), comparing the effects of SGLT2i with PBO in NT-proBNP, ≥ 20% Decrease in NT-proBNP(D) and BNP(E). SGLT2i, SGLT-2 inhibitor, PBO, placebo, Effect stands for WMD = Weighted Mean Difference, CI confidence interval, RR = risk ratioBack to article page